MSD's cancer immunotherapy Keytruda will soon be available as a subcutaneous injection that does away with the need to visit an infusion clinic. Keytruda Qlex (pembrolizumab and berahyaluronidase alfa ...
In 2010, at just 20 years old, Chelsea Ashe started losing vision in her left eye and developed severe double vision. Several ...